|
|
| inobrodib (CCS1477) / CellCentric (0 Trials) |
|
| inodiftagene vixteplasmid (BC 819) / ChemomAb (0 Trials) |
|
| Inomax (nitric oxide) / Mallinckrodt (12 Trials) |
|
| INOpulse (nitric oxide) / Bellerophon Therap (4 Trials) |
|
| Inosars / Inosan Biopharma (0 Trials) |
|
| inosine pranobex / Generic mfg. (0 Trials) |
|
| inositol / NICHD Neonatal Research Network, National Eye Institute (0 Trials) |
|
| Inpefa (sotagliflozin) / Lexicon Pharma (12 Trials) |
|
| Inqovi (decitabine/cedazuridine) / Otsuka (53 Trials) |
|
| INR301 / Imnewrun Biosci (0 Trials) |
|
| INR302 / Imnewrun Biosci (0 Trials) |
|
| INR303 / Imnewrun Biosci (0 Trials) |
|
| INR304 / Imnewrun Biosci (0 Trials) |
|
| Inrebic (fedratinib) / BMS (13 Trials) |
|
| INS018_055 / Insilico Medicine (0 Trials) |
|
| INSB400 / InSitu Biologics (0 Trials) |
|
| Insegia (PAS) / Cancer Advances (0 Trials) |
|
| Insomnia therapy / Reviva (0 Trials) |
|
| Inspiryl Turbuhaler (salbutamol dry-powder inhaler) / AstraZeneca (0 Trials) |
|
| instant release paclitaxel nanoparticles / Optimum Therap (0 Trials) |
|
| Instanyl (fentanyl) / Takeda (13 Trials) |
|
| Insugen 30/70 (recombinant human insulin biosimilar 30% + isophane insulin biosimilar 70%) / Biocon (0 Trials) |
|
| Insugen 50/50 (recombinant human insulin biosimilar 50% + isophane insulin biosimilar 50%) / Biocon (0 Trials) |
|
| Insugen R (recombinant human insulin biosimilar) / Biocon (0 Trials) |
|
| Insugen-N (isophane insulin biosimilar) / Biocon (0 Trials) |
|
| Insulatard (isophane insulin) / Novo Nordisk (12 Trials) |
|
| insulin (NNC0268-0965) / Novo Nordisk (0 Trials) |
|
| insulin aspart 30 / HEC Pharm, Ipsen (0 Trials) |
|
| insulin aspart biosimilar / United Laboratories (0 Trials) |
|
| insulin aspart biosimilar / Lannett, HEC Pharm (0 Trials) |
|
| Insulin biosimilar / Zimmerman Biotech (0 Trials) |
|
| Insulin Bioton (recombinant human insulin biosimilar) / Bioton, AbbVie (0 Trials) |
|
| insulin efsitora alfa (LY3209590) / Eli Lilly (0 Trials) |
|
| insulin glargine biosimilar / United Laboratories (0 Trials) |
|
| insulin glargine biosimilar / Lannett, HEC Pharm (0 Trials) |
|
| Insulin H MIX (rh-insulin/rh-protamine-insulin) / SEDICO (0 Trials) |
|
| Insulin H NPH (protamine sulphate metacresol/recombinant human insulin) / SEDICO (0 Trials) |
|
| insulin oral (NN1954) / Novo Nordisk (0 Trials) |
|
| insulin peglispro (LY2605541) / Eli Lilly (0 Trials) |
|
| insulin R U-500 biosimilar / Biocon (0 Trials) |
|
| insulin tregopil (IN-105) / Biocon (1 Trials) |
|
| insulin-like growth factor / Seurat Therap (0 Trials) |
|
| Insuman Basal (isophane insulin) / Sanofi (3 Trials) |
|
| Insuman Comb 15 (biphasic isophane insulin suspension consisting of 15% dissolved insulin and 85% crystalline protamine insulin) / Sanofi (0 Trials) |
|
| Insuman Comb 25 (biphasic isophane insulin suspension consisting of 25% dissolved insulin and 75% crystalline protamine insulin) / Sanofi (0 Trials) |
|
| Insuman Comb 50 (biphasic isophane insulin suspension consisting of 50% dissolved insulin and 50% crystalline protamine insulin) / Sanofi (0 Trials) |
|
| Insuman Rapid (recombinant human insulin) / Sanofi (3 Trials) |
|
| Insumera (long-acting basal insulin fused to ELP (elastin-like polypeptide) biopolymer) / PhaseBio Pharma (0 Trials) |
|
| INT-1B3 / InteRNA Tech (0 Trials) |
|
| INT-2104 / Interius BioTherap (0 Trials) |
|
| INT-767 / Intercept (0 Trials) |
|
| INT-787 / Intercept (0 Trials) |
|
| INT0024 / IntelGenx (0 Trials) |
|
| INT301 / Intrommune Therap (0 Trials) |
|
| INT41 / Vybion (0 Trials) |
|
| Intacept (etanercept biosimilar) / Intas (0 Trials) |
|
| Intalfa (interferon alfa 2b) / Intas (0 Trials) |
|
| INTASYL based covid therapeutic / Phio Pharma (0 Trials) |
|
| INTASYL sd RNAi targeting CTLA-4 / Phio Pharma (0 Trials) |
|
| Intefen (interferon alpha-2a biosimilar) / Biolotus Biotech, 3SBio (0 Trials) |
|
| Integrilin (eptifibatide) / Takeda (4 Trials) |
|
| Intelence (etravirine) / J&J (0 Trials) |
|
| intepirdine (SB-742457) / Roivant (0 Trials) |
|
| Inter 2A (interferon alpha 2a biosimilar) / Biosidus (1 Trials) |
|
| INTERCEPT-treated coronavirus convalescent plasma / University Hospital Basel, Cerus Corp (0 Trials) |
|
| interferon alpha-2b Paradigm pump infusion system / Medtronic (1 Trials) |
|
| interferon alpha-2b topical (AP-001) / Helix BioPharma (0 Trials) |
|
| interferon alpha-2b XL (IFN alfa-2b XL) / Avadel (0 Trials) |
|
| interferon alpha-5 (IFN alpha 5) / Digna Biotech (0 Trials) |
|
| interferon beta inhalation (SNG001) / Synairgen (1 Trials) |
|
| interferon beta-1a (MOD-9023) / OPKO Health (0 Trials) |
|
| interferon beta-1a biosimilar / AXXO (0 Trials) |
|
| interferon beta-1a ER with Medusa platform / EMD Serono (0 Trials) |
|
| interferon beta-1b / University of Hong Kong (0 Trials) |
|
| interferon gamma inhalational / Relief Therap (0 Trials) |
|
| interferon kappa / Shanghai Public Health Clinical Center (0 Trials) |
|
| interferon omega (ITCA 638) / Intarcia, Boehringer Ingelheim (0 Trials) |
|
| interferon β biobetter (ABN101) / Abion (0 Trials) |
|
| interferon β biosimilar / Kashiv Biosci (0 Trials) |
|
| interferon β biosimilar / Sudershan Biotech (0 Trials) |
|
| interferon β-1b biosimilar / Zydus Lifesci (0 Trials) |
|
| interferon-alpha sustained release (LBSI5536) / LG Chem (0 Trials) |
|
| interleukin 1 beta / Opsona (0 Trials) |
|
| interleukin 10 variants / GenOdyssee (0 Trials) |
|
| Interleukin 12 subunit p40 inhibitor / Angelini Group (0 Trials) |
|
| Interleukin 22 subunit alpha receptor / Merck (MSD) (0 Trials) |
|
| Interleukin 6 inhibitor / Evotec, Interprotein Corp (0 Trials) |
|
| interleukin-2 low dose sublingual / BioLingus, Vitapharm Technology Development (0 Trials) |
|
| interleukin-2 XL (Medusa IL-2 XL) / Avadel (0 Trials) |
|
| interleukin-6 inhibitor / Center of Molecular Immunology (0 Trials) |
|
| Intermezzo (zolpidem) / Paratek (0 Trials) |
|
| intervenolin / Institute of Microbial Chemistry (0 Trials) |
|
| intestinal alkaline phosphatase delayed release (SYN-020) / Theriva Bio (0 Trials) |
|
| intetumumab (CNTO 95) / J&J (0 Trials) |
|
| intra-nasal influenza vaccine / Mymetics (0 Trials) |
|
| intracoronary cardiosphere-derived stem cell therapy (CPI-003) / Capricor (0 Trials) |
|
| Intragam P (intravenous normal human immunoglobulin) / CSL Behring (0 Trials) |
|
| intranasal carbetocin (ACP-101) / Acadia Pharma (0 Trials) |
|
| intranasal Glutathione ((in)GSH) / University of Washington, Bastyr University (0 Trials) |
|
| intranasal insulin / Adhera Therap (0 Trials) |
|
| intranasal orexin positive modulator / Centessa (0 Trials) |
|
| intranasal OX2R agonist / Centessa (0 Trials) |
|
| Intratect (intravenous normal human immunoglobulin) / ADMA Biologics (2 Trials) |
|
| intravenous immunoglobulin (IVIG) / Guys and St Thomas NHS Foundation Trust (1 Trials) |
|
| intravenous normal human immunoglobulin (GCAN 101) / GammaCan International (0 Trials) |
|
| Intravenous Pyridorin (pyridoxamine) / NephroGenex (0 Trials) |
|
| Intrinsa (testosterone transdermal) / AbbVie (0 Trials) |
|
| Intron A (interferon α-2b) / Merck (MSD), Biogen (20 Trials) |
|
| Intuniv (guanfacine XR) / Shionogi, Takeda (9 Trials) |
|
| Intuvax (ilixadencel) / Mendus (0 Trials) |
|
| inupadenant (EOS-850) / iTeos (0 Trials) |
|
| INV-043 injection / Invion (0 Trials) |
|
| INV-043 topical / Invion (0 Trials) |
|
| INV-107 / INVENT Pharma (0 Trials) |
|
| INV-1120 / Ionova Life Sci (0 Trials) |
|
| INV-144 / InVasc Therap (0 Trials) |
|
| INV-155 / InVasc Therap (0 Trials) |
|
| INV-17 oral / Innovimmune Biotherap (0 Trials) |
|
| INV-17 topical / Innovimmune Biotherap (0 Trials) |
|
| INV-201 / Novo Nordisk (0 Trials) |
|
| INV-25 / Innovimmune Biotherap (0 Trials) |
|
| INV-300 SERIES / Novo Nordisk (0 Trials) |
|
| INV-311 / InVasc Therap (0 Trials) |
|
| INV-331 / INVENT Pharma (0 Trials) |
|
| INV-400 / INVENT Pharma (0 Trials) |
|
| INV-404 / InVasc Therap (0 Trials) |
|
| INV-71 / Innovimmune Biotherap (0 Trials) |
|
| INV-88 / Innovimmune Biotherap (0 Trials) |
|
| INV102 / Invirsa (0 Trials) |
|
| INV103 / Invion (1 Trials) |
|
| INV322 / Invenra (0 Trials) |
|
| INV401 / Apeiron Biologics (1 Trials) |
|
| INV441 / Apeiron Biologics (0 Trials) |
|
| INV501 / Apeiron Biologics (0 Trials) |
|
| INV531 / Invenra (0 Trials) |
|
| INV724 / Invenra (0 Trials) |
|
| INVA8003 / Invea Therap (0 Trials) |
|
| INVAC-1 / Invectys (0 Trials) |
|
| Invanz (ertapenem) / Merck (MSD) (0 Trials) |
|
| Invega Hafyera (paliperidone palmitate extended-release 6-month injection) / J&J (1 Trials) |
|
| Invega Sustenna (paliperidone palmitate extended-release 1-month injection) / J&J (7 Trials) |
|
| Invega Trinza (paliperidone palmitate extended-release 3-month injection) / J&J (3 Trials) |
|
| Inveltys (loteprednol etabonate nano-suspension 1%) / Kala Pharma (0 Trials) |
|
| Invicorp (aviptadil/phentolamine mesilate) / Regent Pacific Group (0 Trials) |
|
| invikafusp alfa (STAR0602) / Marengo (0 Trials) |
|
| Invirase (saquinavir) / Roche (0 Trials) |
|
| InvisiMask / Eureka Therap (0 Trials) |
|
| Invokana (canagliflozin) / J&J, Daiichi Sankyo, Mitsubishi Tanabe (40 Trials) |
|
| Invossa (tonogenchoncel-L) / Kolon Life Sci (0 Trials) |
|
| INX 005 / BMS (0 Trials) |
|
| INX 189 / BMS (0 Trials) |
|
| INX-315 / Incyclix Bio, G1 Therap (0 Trials) |
|
| INXN-3001 / Precigen, Alaunos Therap (0 Trials) |
|
| INXN-4001 / Precigen (0 Trials) |
|
| INZ701 / Inozyme Pharma (0 Trials) |
|
| inzomelid (IZD174) / Roche (0 Trials) |
|
| IO-1 / Oxurion (0 Trials) |
|
| IO-10 / KSQ Therap (0 Trials) |
|
| IO-106 / Immune-Onc Therap (0 Trials) |
|
| IO-108 / Immune-Onc Therap (0 Trials) |
|
| IO-160 / IO Biotech (0 Trials) |
|
| IO-202 / Immune-Onc Therap (0 Trials) |
|
| IO-312 / Immune-Onc Therap (0 Trials) |
|
| IO101 / IO Biotech (0 Trials) |
|
| IO102 / IO Biotech (1 Trials) |
|
| IO102-IO103 / IO Biotech (0 Trials) |
|
| IO103 / IO Biotech (0 Trials) |
|
| IO112 / IO Biotech (0 Trials) |
|
| IO120 / IO Biotech (0 Trials) |
|
| IOA-237 / iOnctura (0 Trials) |
|
| iodine 131 labeled acitretide (DK001) / Shanghai Haikang (0 Trials) |
|
| IodoCarb (iodinated activated charcoal) / PharmaLundensis (0 Trials) |
|
| IODVA1 / University of Cincinnati (0 Trials) |
|
| Iomab-ACT / Actinium (0 Trials) |
|
| Iomab-B (I-131-apamistamab) / Actinium, Immedica (1 Trials) |
|
| ION 674 / Ionis (0 Trials) |
|
| Ion channel blockers / Newron (0 Trials) |
|
| ion channel modulator / Saniona, Novartis (0 Trials) |
|
| Ion channel modulators / Pfizer (0 Trials) |
|
| ion channel modulators / Ligand, Roche (0 Trials) |
|
| ION-283 / Ionis (0 Trials) |
|
| ION-663 / Ionis (0 Trials) |
|
| ION224 / Ionis (1 Trials) |
|
| ION253 / J&J (0 Trials) |
|
| ION260 / Ionis, Biogen (0 Trials) |
|
| ION455 / Ionis (0 Trials) |
|
| ION537 / Ionis (0 Trials) |
|
| ION541 / Biogen (0 Trials) |
|
| ION547 / Ionis (0 Trials) |
|
| ION581 / Ionis, Biogen (0 Trials) |
|
| ION582 / Ionis, Biogen (0 Trials) |
|
| ION904 / Ionis (0 Trials) |
|
| IONIS-AGT-LRx / Ionis (0 Trials) |
|
| IONIS-AR-2.5Rx / Flamingo Therapeutics (1 Trials) |
|
| IONIS-FGFR4Rx / Ionis (1 Trials) |
|
| IONIS-FXIRx / Bayer (0 Trials) |
|
| IONIS-GCGRRx / Ionis (0 Trials) |
|
| IONIS-JBI1-2.5Rx / J&J (0 Trials) |
|
| IONIS-MAPTRx / Biogen (1 Trials) |
|
| IONIS-PKKRx / Ionis (1 Trials) |
|
|